Deirdre Nieidhin

Title: Deirdre Nieidhin: Innovator in Coagulase-Negative Staphylococcal Research

Introduction

Deirdre Nieidhin is a prominent inventor based in The Coombe, Ireland. She has made significant contributions to the field of microbiology, particularly in the study of coagulase-negative staphylococci. Her innovative work has led to the development of valuable patents that aim to improve the diagnosis and treatment of infections caused by these bacteria.

Latest Patents

Deirdre Nieidhin holds a patent for "Proteins and polypeptides from coagulase-negative staphylococci." This patent includes proteins designated SdrF, SdrG, and SdrH, along with their effective fragments, which are crucial in preventing and treating infections caused by coagulase-negative staphylococcal bacteria. The SdrF, SdrG, and SdrH proteins are cell-wall associated proteins that specifically bind to host proteins. Each of these proteins contains a highly conserved motif, with the consensus sequence being TYTFTDYVD (SEQ ID NO: 16). The proteins and polypeptides may also be useful in generating antibodies for the diagnosis and treatment of coagulase-negative staphylococcal infections.

Career Highlights

Throughout her career, Deirdre has worked with esteemed institutions, including the Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth, near Dublin, and the Texas A&M University System. Her research has garnered attention for its potential impact on public health and medical treatments.

Collaborations

Deirdre has collaborated with notable colleagues, including Timothy James Foster and Kirk McCrea. These partnerships have furthered her research and contributed to advancements in the field.

Conclusion

Deirdre Nieidhin is a trailblazer in the study of coagulase-negative staphylococci, with a patent that holds promise for improving infection treatment. Her work exemplifies the importance of innovation in addressing medical challenges.